Search clinical trials for: PET/CT analysis

Total 14444 results

Institute of Oncology Ljubljana

Active, not recruiting

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

Melanoma | PET CT

Slovenia
Tata Memorial Centre
Indian Statistical Institute, Kolkata

Active, not recruiting

Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis (GLIO-RAD)

Glioma

India
China National Center for Cardiovascular Diseases

Unknown

Registration Study of Takayasu's Arteritis in China (TA-China)

Takayasu Arteritis

China
Assistance Publique Hopitaux De Marseille

Terminated

Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study

Breast Carcinoma

France
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Recruiting

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
Sun Yat-sen University

Unknown

Post-treatment Ultrasensitive Positron Emission Tomography in Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
University Hospital, Basel, Switzerland
Swiss Foundation for the Study of Muscular Diseases

Completed

Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

Giant Cell Arteritis | Large Vessel Giant Cell Arteriitis

Switzerland
Peter MacCallum Cancer Centre, Australia
Melbourne Health; Westmead Hospital; Victorian Infectious Diseases Reference...

Completed

PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia (PIPPIN)

Acute Myeloid Leukemia | Febrile Neutropenia | Acute Lymphoblastic Leukemia | Haematopoietic Stem Cell Transplant, Autologous | Haematopoietic Stem Cell Transplant, Allogeneic

Australia
HALO Diagnostics

Completed

A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer

Prostate Cancer

United States
Massachusetts General Hospital
National Cancer Institute (NCI)

Completed

Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas

Chordoma

United States
Washington University School of Medicine

Terminated

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Cervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical Cancer

United States
Advanced Imaging Projects, LLC
All India Institute of Medical Sciences, New Delhi; US Department of Veterans... and other collaborators

Not yet recruiting

Safety and Efficacy of Ga68 Αvβ3 IAC PET/CT for Diagnosis and Clinical Management in Angiogenic Breast Cancer Patients (Shiva)

Angiogenic Breast Cancer

South Africa, India
University of Utah
National Cancer Institute (NCI)

Completed

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

Venothromboembolism

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer

Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M) | Untreated Bone Metastases

United States
The Catholic University of Korea

Unknown

Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Korea, Republic of
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

Clear Cell Renal Cell Carcinoma

China
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics

Breast Neoplasms | Prostatic Neoplasms
M.D. Anderson Cancer Center

Completed

Feasibility Study for Imaging of Peripheral Tumors With a High-Resolution PET Imaging System

Cancer | Solid Tumors

United States
University of Texas Southwestern Medical Center

Withdrawn

Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET

Breast Cancer

United States
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Renal Cell Carcinoma

China
Peking Union Medical College Hospital

Recruiting

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

Clear Cell Renal Cell Carcinoma

China
University of Vermont

Terminated

Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy

Prostatic Neoplasm

United States
University Hospital of North Norway

Terminated

PET/MR Imaging in Lung Cancer

Lung Cancer

Norway
NYU Langone Health
Dendreon

Terminated

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
University College, London
King's College London; Rambam Health Care Campus; University of Melbourne; Menzies... and other collaborators

Not yet recruiting

18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia (PET-SAB)

Sepsis | Staphylococcus Aureus Infection | Bloodstream Infection | Staphylococcus Aureus Bacteremia | Sepsis Bacterial | Staphylococcus Aureus Septicemia | Staph Sepsis
Ontario Clinical Oncology Group (OCOG)
Cancer Care Ontario

Active, not recruiting

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging (PET MUSE)

Muscle-invasive Bladder Cancer

Canada
Herlev Hospital

Completed

Diagnostic Imaging of Myeloma Bone Lesions (RAMP)

Multiple Myeloma

Denmark
Massachusetts General Hospital

Recruiting

Evaluation of PET/MRI in Children With Cancer

Hematologic Malignancy

United States
Xuzhou Medical University

Unknown

PET-CT/MRI in the Radiotherapy for Prostate Cancer

Prostate Cancer
Massachusetts General Hospital

Unknown

PET-CT vs. Integrated MR-PET Scanning of GYN Cancers

Cervical Cancer | Ovarian Cancer | Endometrial Cancer

United States
University of Pittsburgh

Terminated

Phase III Trial of PET/CT vs. CTSurveilance for Head and Neck Cancer

Carcinoma, Squamous Cell of Head and Neck

United States
M.D. Anderson Cancer Center

Completed

PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma

Melanoma

United States
Insel Gruppe AG, University Hospital Bern

Recruiting

Assessing Ultra-low Dose PET/CT and CT-less PET Using a Long Axial Field-of-view PET/CT System (ULD-PET)

PET/CT

Switzerland
University of Sao Paulo

Unknown

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Rectal Cancer

Brazil
Washington University School of Medicine

Recruiting

64Cu-LLP2A for Imaging Multiple Myeloma

Multiple Myeloma

United States
Turku University Hospital
GE Healthcare; Blue Earth Diagnostics

Completed

Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI (Flucipro)

Prostate Carcinoma

Finland
National Cancer Institute, Naples

Active, not recruiting

PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy (PETRA)

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB

Italy
University Hospital, Grenoble

Unknown

Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity. (ORNICA)

Squamous Cell Carcinoma of the Oral | Clinically Node-Negative and Radiology

France
Lung Clinic Heckeshorn

Completed

Clinical Evaluation of PET-CT for Staging of Colorectal Lung Metastases

Metastatic Colorectal Cancer

Germany
Barts & The London NHS Trust

Unknown

Development and Validation of a Fast, Semi-Automated Hybrid Imaging Platform to Assess Coronary Atherosclerotic Plaque Morphology, Endothelial Shear Stress and Arterial Inflammation: A Proof of Principle Study (VALID-PET-CT) (VALID-PET-CT)

Coronary Artery Disease | Stable Angina
Institut Bergonié

Unknown

Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer (TEP Vessie)

Muscle Invasive Bladder Cancer

France
National Cancer Institute (NCI)

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Neurofibromatosis | MPNST

United States
Guangdong Provincial People's Hospital

Recruiting

Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors (FAPI)

Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Mucinous Adenocarcinoma | Signet Ring Cell Carcinoma

China
Hoag Memorial Hospital Presbyterian

Active, not recruiting

18F-fluoroestradiol (FES) PET/CT for Breast Cancer

Breast Cancer

United States
Aya Khaled Mahmoud

Not yet recruiting

Role of PET/CT in Peritoneal Deposits Assessment

Peritoneal Metastases
Johns Hopkins University

Recruiting

PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography] (PET; CT)

Coronary Artery Disease | Atherosclerosis | Coronary Atherosclerosis of Native Coronary Artery

United States
University Hospital, Ghent

Recruiting

Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.

Breast Neoplasms | Breast Cancer Female

Belgium
Queensland Centre for Gynaecological Cancer
Royal Brisbane and Women's Hospital; The University of Queensland

Completed

Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer (IMAGE)

Ovarian Cancer Stage IV | Ovarian Cancer Stage III

Australia
Assistance Publique Hopitaux De Marseille

Completed

Comparison of Diagnostic Performances of 68Ga-DOTATATE PET-CT and 18F-FDOPA PET-CT in Paragangliomas and Pheochromocytomas Evaluation (DOTATATE)

Paragangliomas | Pheochromocytomas

France

Search clinical trials for: PET/CT analysis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations